ConforMIS Gets Personal With $89 Million Round
ConforMIS last month closed on an $89 million Series E round to help pay for the company’s commercial launch of iTotal, customized, patient-specific total knee implants.
ConforMIS last month closed on an $89 million Series E round to help pay for the company’s commercial launch of iTotal, customized, patient-specific total knee implants.